KOSDAQ · Healthcare · ₩2T
₩39,400-1.50%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 21.7% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“제품 효율이 좋아져 매출보다 이익이 더 탄탄해졌어요.”
In the company's words · 2026 2분기 filing